---
title: Evaluation of Coagulation and Inflammatory Markers in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)
description: Evaluation of Coagulation and Inflammatory Markers in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)
---

[![functionalfluidics\_logo](https://www.functionalfluidics.com/hs-fs/hubfs/functionalfluidics_logo.jpg?width=132&name=functionalfluidics_logo.jpg)](https://www.functionalfluidics.com/)

- [About Us](https://www.functionalfluidics.com/about-us)
- [Services](https://www.functionalfluidics.com/services)
- [Assays](https://www.functionalfluidics.com/assays-2) 
    - [Flow Adhesion](https://www.functionalfluidics.com/assays/flow-adhesion)
    - [Mechanical Fragility](https://www.functionalfluidics.com/assays/mechanical-fragility)
    - [Dynamic Sickling Assay](https://www.functionalfluidics.com/assays-dynamicsicklingassay)
    - [Oxygenscan](https://www.functionalfluidics.com/assays/lorrca-oxygenscan)
    - [Osmoscan](https://www.functionalfluidics.com/assays-2/flow-adhesion-reverse-0)
- [Contract Research](https://www.functionalfluidics.com/contractresearch) 
    - [Nigeria Research Center](https://www.functionalfluidics.com/functional_fluidics_nigeria)
    - [RBC Test Menu](https://www.functionalfluidics.com/hubfs/Test%20Menu%20(2).pdf)
- Scientific Resources 
    - [Peer Reviewed Publications](https://www.functionalfluidics.com/scientificresources/peerreviewed)
    - [Abstracts](https://www.functionalfluidics.com/scientificresources/abstracts)
    - [ELIPSIS](https://www.functionalfluidics.com/scientificresources/elipsis)
- [News](https://www.functionalfluidics.com/news-and-presentations)

## Evaluation of Coagulation and Inflammatory Markers in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)

Evaluation of Coagulation and Inflammatory Markers in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)

- <http://www.facebook.com/sharer/sharer.php?u=https://www.functionalfluidics.com/publications/evaluation-of-coagulation-and-inflammatory-markers-in-pediatric-patients-on-extracorporeal-membrane-oxygenation-ecmo>
- <https://twitter.com/intent/tweet?text=Evaluation+of+Coagulation+and+Inflammatory+Markers+in+Pediatric+Patients+on+Extracorporeal+Membrane+Oxygenation+%28ECMO%29%20@aliceapp&url=https://www.functionalfluidics.com/publications/evaluation-of-coagulation-and-inflammatory-markers-in-pediatric-patients-on-extracorporeal-membrane-oxygenation-ecmo>
- <https://www.linkedin.com/cws/share?url=https://www.functionalfluidics.com/publications/evaluation-of-coagulation-and-inflammatory-markers-in-pediatric-patients-on-extracorporeal-membrane-oxygenation-ecmo>

 March 18, 2021

0% read

 Subscribe to our Newsletter

Background: 

Bleeding and thrombosis remain the primary complications related to the use of extracorporeal membrane oxygenation (ECMO). To date, no single test or parameter has been identified to accurately predict the risk of these hemostatic complications. Thrombin generation may be the key marker for both thrombosis and bleeding, and may be influenced by inflammation. The aims of this study were to evaluate if novel laboratory tests including thrombin generation assay, neutrophil extracellular traps (NETs), microparticles (MPs), and red blood cell (RBC) membrane fragility/adhesion could better predict patients at risk for bleeding and/or thrombosis compared to routine laboratory tests. We hypothesized that ECMO related thrombosis is associated with increased thrombin generation and ECMO related bleeding is associated with decreased thrombin generation.

[https://ashpublications.org/blood/article/136/Supplement%201/14/473200/Evaluation-of-Coagulation-and-Inflammatory-Markers](https://ashpublications.org/blood/article/136/Supplement%201/14/473200/Evaluation-of-Coagulation-and-Inflammatory-Markers)  

 Subscribe to our Newsletter

 Subscribe to our Newsletter

### ### Recommended Reads

![](https://www.functionalfluidics.com/hubfs/Screenshot%202025-12-01%20105529.png)

Dec 1, 2025

#### [Functional Fluidics Welcomes Biopharma Leader Bert Bruce as Senior Advisor](https://www.functionalfluidics.com/publications/functional-fluidics-welcomes-biopharma-leader-bert-bruce-as-senior-advisor)

![](https://www.functionalfluidics.com/hubfs/Screenshot%202025-11-30%20195918.png)

Dec 1, 2025

#### [Functional Fluidics to Present New Sickle Cell Disease Data at the 2025 ASH Annual Meeting in Orlando, Florida](https://www.functionalfluidics.com/publications/functional-fluidics-to-present-new-sickle-cell-disease-data-at-the-2025-ash-annual-meeting-in-orlando-florida)

### Contact Us

 

# **Our Location**

440 Burroughs Street,  
Suite 447, Detroit, MI 48202  
United States

Email: [info@functionalfluidics.com](mailto:info@functionalfluidics.com)  
Phone:313-315-2555

### Subscribe to Our Newsletter

- [Services](https://www.functionalfluidics.com/services)
- [Assays](https://www.functionalfluidics.com/assays-2)
- [RBC Test Menu](https://www.functionalfluidics.com/hubfs/Test%20Menu%20(2).pdf)
- [Publications](https://www.functionalfluidics.com/publications/tag/publications)

© Copyright Functional Fluidics 2016.